Literature DB >> 18535784

TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme.

L Verstrepen1, T Bekaert, T-L Chau, J Tavernier, A Chariot, R Beyaert.   

Abstract

Toll-like receptors (TLRs) as well as the receptors for tumor necrosis factor (TNF-R) and interleukin-1 (IL-1R) play an important role in innate immunity by regulating the activity of distinct transcription factors such as nuclear factor-kappaB (NF-kappaB). TLR, IL-1R and TNF-R signaling to NF-kappaB converge on a common IkappaB kinase complex that phosphorylates the NF-kappaB inhibitory protein IkappaBalpha. However, upstream signaling components are in large part receptor-specific. Nevertheless, the principles of signaling are similar, involving the recruitment of specific adaptor proteins and the activation of kinase cascades in which protein-protein interactions are controlled by poly-ubiquitination. In this review, we will discuss our current knowledge of NF-kappaB signaling in response to TLR-4, TNF-R and IL-1R stimulation, with a special focus on the similarities and dissimilarities among these pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535784     DOI: 10.1007/s00018-008-8064-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  158 in total

1.  Autophagy suppresses interleukin-1β (IL-1β) signaling by activation of p62 degradation via lysosomal and proteasomal pathways.

Authors:  Jongdae Lee; Hye Ri Kim; Christine Quinley; Joanna Kim; Jose Gonzalez-Navajas; Ramnik Xavier; Eyal Raz
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 2.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

Review 3.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 4.  Signaling to NF-kappaB: regulation by ubiquitination.

Authors:  Ingrid E Wertz; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 5.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

6.  PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1.

Authors:  Hyun Jung Lee; Sung Hee Jang; Hyeyoung Kim; Joo Heon Yoon; Kwang Chul Chung
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

7.  Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.

Authors:  Jerry C Lee; Jennifer L Greenwich; George G Zhanel; Xiaobing Han; Andrew Cumming; Laura Saward; Rachel M McLoughlin
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

8.  Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors.

Authors:  D De Silva; M D Mitchell; J A Keelan
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 9.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

10.  TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.

Authors:  Ming-Ming Hu; Qing Yang; Jing Zhang; Shi-Meng Liu; Yu Zhang; Heng Lin; Zhe-Fu Huang; Yan-Yi Wang; Xiao-Dong Zhang; Bo Zhong; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.